techMARK (TASX)

Up
Value:
4,381.04
Change Today:
47.43

Latest ShareCast News

UK to give under 40s alternative to AstraZeneca vaccine

By Caoimhe Toman

Date: Friday 07 May 2021

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

Meggitt surges as Woodward said to explore possible acquisition

By Michele Maatouk

Date: Friday 07 May 2021

(Sharecast News) - Meggitt shares surged on Friday following a report that US-based Woodward Inc could be looking to buy the London-listed aerospace engineer.

AstraZeneca's Imfinzi demonstrates benefit in combination with antibody

By Josh White

Date: Friday 07 May 2021

(Sharecast News) - AstraZeneca reported on Friday that 'Imfinzi' and tremelimumab with chemotherapy demonstrated an overall survival benefit in the 'POSEIDON' trial for first-line stage four non-small cell lung cancer, making it the first phase 3 trial to demonstrate an overall survival benefit with tremelimumab.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 4,381.04
Change Today 47.43
07-May-21 Close 4,381.04